Tsumura & Co 2022 IR
The report outlines Tsumura & Co.'s progress and strategies under its new long-term management vision, TSUMURA VISION 'Cho-WA' 2031, and its Sustainability Vision, 'Living with nature for tomorrow.' Key highlights from fiscal 2021 include expanding its domestic Kampo formulations business, growing its Chinese operations to ten billion yen, and establishing a new Chief Human Resources Officer position to drive organizational capital. The company also reported a 50% reduction target for Scope 1 and 2 greenhouse gas emissions by fiscal 2030 and achieved a 79.6% ratio of proprietarily managed fields for crude drug procurement.
Company: Tsumura & Co
Sector: Health Care
Country: Japan
Year: 2022
Type: IR
Pages: 96
Tsumura & Co
Integrated Report
The report outlines Tsumura & Co.'s progress and strategies under its new long-term management vision, TSUMURA VISION 'Cho-WA' 2031, and its Sustainability Vision, 'Living with nature for tomorrow.' Key highlights from fiscal 2021 include expanding its domestic Kampo formulations business, growing its Chinese operations to ten billion yen, and establishing a new Chief Human Resources Officer position to drive organizational capital. The company also reported a 50% reduction target for Scope 1 and 2 greenhouse gas emissions by fiscal 2030 and achieved a 79.6% ratio of proprietarily managed fields for crude drug procurement.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2022
Reporting Period
Apr 1, 2021 - Mar 31, 2022
Fiscal Year
2021
Type
Integrated Report
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Women on Board
Women in Management
Net Zero Target
Employees